ArticlePharmacy practice
Challenges in the management of chronic noncommunicable diseases by Indonesian community pharmacists.
Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Primary health care roles of community pharmacists in low- and middle-income countries: a mixed methods systematic review.BMC health services research · 2025Pooled it
- Access to hypertension care and services in primary health-care settings in Vietnam: a systematic narrative review of existing literature.Global health action · 2019Pooled it
- Pharmacists' perspectives on medication therapy management training needs for chronic disease care in Indonesian primary healthcare centers: a qualitative study across 32 provinces.BMC medical education · 2026Article
- A narrative review of pharmacy workforce challenges in Indonesia.Human resources for health · 2025Review
- Exploration of Challenges and Opportunities for Good Pharmacy Practices in Bangladesh: A Qualitative Study.Pharmacy (Basel, Switzerland) · 2025Article
- The incentivized drug information services among community pharmacists: a multi-centre cross-sectional study in Indonesia.Primary health care research & development · 2025Article
- How Does Indonesian Chronic Disease Patient Adhere to Their Treatment? A Cross-Sectional Analysis of 11,408 Subjects.Patient preference and adherence · 2025Article
- Drug-Related Problems Detected in Complex Chronic Patients by Community Pharmacists of Catalonia: Perception of the Person-Centred Approach Necessity.Healthcare (Basel, Switzerland) · 2024Article
- Pharmacists and Pharmacy Technicians' Perceptions of Scopes of Practice Employing Agency Theory in the Management of Minor Ailments in Central Indonesian Community Pharmacies: A Qualitative Study.Pharmacy (Basel, Switzerland) · 2023Article
- The extent and barriers in providing pharmaceutical care services by community pharmacists in Malaysia: a cross-sectional study.BMC health services research · 2021Observational
- Perspectives of community pharmacists in Pakistan about practice change and implementation of extended pharmacy services: a mixed method study.International journal of clinical pharmacy · 2021Article
- Quality of tuberculosis care by pharmacies in low- and middle-income countries: Gaps and opportunities.Journal of clinical tuberculosis and other mycobacterial diseases · 2020Article
- How have researchers defined and used the concept of 'continuity of care' for chronic conditions in the context of resource-constrained settings? A scoping review of existing literature and a proposed conceptual framework.Health research policy and systems · 2019Article
- Primary health care policy and vision for community pharmacy and pharmacists in Indonesia.Pharmacy practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesWe explored factors influencing Indonesian primary care pharmacists' practice in chronic noncommunicable disease management and proposed a model illustrating relationships among factors.
methodsWe conducted in-depth, semistructured interviews with pharmacists working in community health centers (Puskesmas, n=5) and community pharmacies (apotek, n=15) in East Java Province. We interviewed participating pharmacists using Bahasa Indonesia to explore facilitators and barriers to their practice in chronic disease management. We audiorecorded all interviews, transcribed ad verbatim, translated into English and analyzed the data using an approach informed by "grounded-theory".
resultsWe extracted five emergent themes/factors: pharmacists' attitudes, Puskesmas/apotek environment, pharmacy education, pharmacy professional associations, and the government. Respondents believed that primary care pharmacists have limited roles in chronic disease management. An unfavourable working environment and perceptions of pharmacists' inadequate knowledge and skills were reported by many as barriers to pharmacy practice. Limited professional standards, guidelines, leadership and government regulations coupled with low expectations of pharmacists among patients and doctors also contributed to their lack of involvement in chronic disease management. We present the interplay of these factors in our model.
conclusionPharmacists' attitudes, knowledge, skills and their working environment appeared to influence pharmacists' contribution in chronic disease management. To develop pharmacists' involvement in chronic disease management, support from pharmacy educators, pharmacy owners, professional associations, the government and other stakeholders is required. Our findings highlight a need for systematic coordination between pharmacists and stakeholders to improve primary care pharmacists' practice in Indonesia to achieve continuity of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.